Skip to main navigation Skip to search Skip to main content

Successful management of feline pemphigus foliaceus with pentoxifylline and topical hydrocortisone aceponate

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

252 Downloads (CityUHK Scholars)

Abstract

The treatment regimen for feline pemphigus foliaceus (PF), an autoimmune disease caused by auto-antibodies against proteins of the desmosome junction, usually includes high doses of oral or parenteral immunosuppressive drugs, typically glucocorticoids. This case adds to a growing body of evidence that topical hydrocortisone aceponate is effective for the treatment of feline PF, and demonstrates the practical use of a non-invasive diagnostic method for histopathology when owners refuse a biopsy to support a clinical diagnosis of PF. Finally, this case highlights an international trend of owner-initiated treatment of feline infectious peritonitis (FIP) using unlicensed, unregistered drugs.
Original languageEnglish
Pages (from-to)937-944
JournalVeterinary Medicine and Science
Volume8
Issue number3
Online published25 Feb 2022
DOIs
Publication statusPublished - May 2022

Research Keywords

  • autoimmune disease
  • dermatology
  • feline
  • pemphigus
  • skin
  • treatment

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'Successful management of feline pemphigus foliaceus with pentoxifylline and topical hydrocortisone aceponate'. Together they form a unique fingerprint.

Cite this